…
Wellbeing Digital Sciences Inc., a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as KetamineOne Capital Limited and changed its name to Wellbeing Digital Sciences Inc. in January 2022. Wellbeing Digital Sciences Inc. was founded in 2017 and is headquartered in Vancouver, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
KetamineOne Capital Limited is an investment and development company listed on the US OTC Pink market that focuses on ketamine and other psychedelic-based therapies and related assets. Long-term growth drivers may include rising demand for novel mental-health treatments, progress in clinical research and potential regulatory acceptance, which may provide exposure to an emerging therapeutics market.
Key risks include limited public information and low liquidity typical of OTC Pink small caps, regulatory and clinical-trial uncertainty in psychedelics, need for additional financing, and execution risk for early-stage assets.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
| Income before tax | - | -31.91M | 1.13M | -6.58M | -0.29M |
| Net income | - | -31.91M | 1.13M | -6.58M | -0.29M |
| Selling general administrative | - | 8.61M | 0.60M | 0.60M | 0.29M |
| Selling and marketing expenses | - | 0.08M | 0.01M | - | - |
| Gross profit | - | 0.79M | - | - | - |
| Reconciled depreciation | - | 0.28M | 0.03M | - | - |
| Ebit | -25.03M | -8.06M | -0.61M | -0.45M | -0.22M |
| Ebitda | - | -7.77M | -0.58M | 5.39M | -0.29M |
| Depreciation and amortization | - | 0.28M | 0.03M | - | - |
| Operating income | - | -8.06M | -0.61M | 5.39M | -0.29M |
| Other operating expenses | - | 9.31M | 0.64M | 0.60M | 0.29M |
| Interest expense | - | 0.03M | 0.01M | 0.00M | 0.00M |
| Interest income | - | - | 0.03M | 0.02M | - |
| Net interest income | - | -0.03M | 0.02M | 0.02M | - |
| Income tax expense | - | 0.15M | 0.01M | - | - |
| Total revenue | - | 1.13M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | - | 8.97M | 0.64M | 0.60M | 0.29M |
| Cost of revenue | - | 0.34M | - | - | - |
| Total other income expense net | - | -23.71M | 1.75M | -5.99M | - |
| Net income from continuing ops | - | -31.91M | 1.13M | -6.58M | -0.29M |
| Net income applicable to common shares | -25.21M | -31.91M | 1.13M | -6.58M | -0.29M |
| Breakdown | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
| Total assets | - | 21.92M | 4.92M | 3.73M | 2.12M |
| Intangible assets | - | 3.50M | - | - | - |
| Other current assets | 0.06M | 0.06M | 0.06M | 0.12M | - |
| Total liab | - | 14.01M | 0.08M | 0.02M | 0.04M |
| Total stockholder equity | - | 7.91M | 4.84M | 3.71M | 2.08M |
| Deferred long term liab | 2.44M | 2.74M | - | - | - |
| Other current liab | 0.00M | 1.29M | 0.03M | - | - |
| Common stock | 45.17M | 40.30M | 10.53M | 10.53M | 2.35M |
| Capital stock | - | 40.30M | 10.53M | 10.53M | 2.35M |
| Retained earnings | -63.23M | -37.61M | -5.69M | -6.82M | -0.32M |
| Other liab | 12.04M | 12.48M | - | - | - |
| Good will | - | 10.30M | - | - | - |
| Other assets | 2.44M | 2.74M | - | - | - |
| Cash | - | 3.32M | 2.52M | 3.19M | 2.12M |
| Total current liabilities | 5.38M | 1.53M | 0.06M | 0.02M | 0.04M |
| Net debt | - | -3.08M | -2.47M | -3.19M | -2.12M |
| Short term debt | - | 0.24M | 0.03M | - | - |
| Short long term debt total | - | 0.24M | 0.05M | - | - |
| Other stockholder equity | 17.82M | 5.22M | 0.01M | 0.01M | 0.05M |
| Property plant equipment | 0.27M | 0.44M | 0.05M | - | - |
| Total current assets | 1.42M | 4.94M | 4.87M | 3.33M | 2.12M |
| Long term investments | - | - | - | 0.40M | - |
| Net tangible assets | -13.32M | -5.89M | 4.84M | 3.71M | 2.08M |
| Short term investments | - | 0.30M | 2.24M | - | - |
| Net receivables | 0.76M | 0.80M | - | - | - |
| Accounts payable | 3.04M | 1.29M | 0.03M | 0.02M | 0.04M |
| Non currrent assets other | - | 2.74M | - | - | - |
| Non current assets total | - | 16.98M | 0.05M | 0.40M | 0.00M |
| Capital lease obligations | - | 0.24M | 0.05M | - | - |
| Breakdown | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 | 2018-07-31 |
| Investments | - | 0.12M | -0.04M | -1.65M | -1.65M |
| Change to liabilities | 2.79M | 1.17M | 0.01M | -0.02M | 0.03M |
| Total cashflows from investing activities | -1.09M | -1.23M | -0.04M | -1.76M | -1.76M |
| Net borrowings | 1.41M | -0.27M | -0.04M | -0.04M | -0.04M |
| Total cash from financing activities | 1.72M | 4.28M | -0.04M | 3.47M | 2.25M |
| Change to operating activities | 0.57M | -0.70M | -0.02M | -0.03M | -0.03M |
| Net income | -25.21M | -31.91M | 1.13M | -6.58M | -0.29M |
| Change in cash | -3.00M | 0.80M | -0.67M | 1.07M | 2.04M |
| Begin period cash flow | 3.32M | 2.52M | 3.19M | 2.12M | 0.08M |
| End period cash flow | - | 3.32M | 2.52M | 3.19M | 2.12M |
| Total cash from operating activities | -3.64M | -2.28M | -0.59M | -0.64M | -0.21M |
| Issuance of capital stock | - | 4.54M | 0.00M | 3.50M | - |
| Depreciation | 1.25M | 0.28M | 0.03M | 0.03M | 0.03M |
| Other cashflows from investing activities | - | - | - | -0.12M | -0.12M |
| Change to account receivables | -0.10M | -0.65M | -0.65M | -0.65M | -0.65M |
| Sale purchase of stock | - | - | 0.00M | -0.03M | - |
| Other cashflows from financing activities | - | 0.01M | -0.04M | 0.01M | 0.01M |
| Change to netincome | 17.07M | 29.52M | -1.74M | 5.99M | 0.04M |
| Capital expenditures | 0.09M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | - | -0.18M | -0.01M | -0.05M | 0.03M |
| Stock based compensation | - | 5.22M | - | 0.00M | 0.04M |
| Other non cash items | - | 24.31M | -1.74M | 5.99M | - |
| Free cash flow | - | -2.28M | -0.59M | -0.64M | -0.21M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare, Inc. |
-1.50 0.30% |
503.39 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
-0.68 0.24% |
288.32 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.34 2.34% |
14.86 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
0.29 5.59% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Wellbeing Digital Sciences Inc., a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as KetamineOne Capital Limited and changed its name to Wellbeing Digital Sciences Inc. in January 2022. Wellbeing Digital Sciences Inc. was founded in 2017 and is headquartered in Vancouver, Canada.
1917 West 4th Avenue, Vancouver, BC, Canada, V6J 1M7
| Name | Title | Year Born |
|---|---|---|
| Ms. Najla Guthrie | CEO, Chief Research Officer & Director | NA |
| Mr. Terry Zimaro C.A., CPA | Chief Financial Officer | 1975 |
| Natalie Dolphin | VP of Marketing & Investment Relations | NA |
| Mr. Keith White | Pres of Clinic Operations | NA |
| Ms. Najla Guthrie | CEO, Chief Research Officer & Director | 1964 |
| Mr. Keith White | President of Clinic Operations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.